Cipla informs about press release

26 Mar 2020 Evaluate

Cipla has informed that the company has enclosed press release dated 26th March 2020 regarding ‘Cipla receives final approval for generic version of AstraZeneca Pharmaceutical’s Nexium (Esomeprazole for Oral Suspension 10mg, 20mg and 40mg)’.

The above information is a part of company’s filings submitted to BSE.

Cipla Share Price

1319.10 -1.25 (-0.09%)
30-Jan-2026 11:29 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1587.60
Dr. Reddys Lab 1217.35
Cipla 1319.10
Zydus Lifesciences 884.40
Lupin 2132.50
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×